Published in J Acquir Immune Defic Syndr Hum Retrovirol on November 01, 1995
Robustness and evolvability: a paradox resolved. Proc Biol Sci (2008) 3.08
HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing. Proc Natl Acad Sci U S A (1997) 1.06
Neutral network sizes of biological RNA molecules can be computed and are not atypically small. BMC Bioinformatics (2008) 1.05
Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs. Mol Cell Biol (2000) 0.93
Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains. PLoS One (2012) 0.85
Mutational robustness accelerates the origin of novel RNA phenotypes through phenotypic plasticity. Biophys J (2014) 0.82
HIV-1 Rev oligomerization is not obligatory in the presence of an extra basic domain. Retrovirology (2005) 0.79
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell (1986) 10.76
A novel, highly stable fold of the immunoglobulin binding domain of streptococcal protein G. Science (1991) 6.00
Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III. Nature (1986) 5.24
IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 4.52
Visualization of a 4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature (1997) 4.35
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant (2001) 4.02
Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J (1998) 3.77
The yeast homologue of U3 snRNA. EMBO J (1987) 3.74
NMR structure of a specific DNA complex of Zn-containing DNA binding domain of GATA-1. Science (1993) 3.74
The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry (1996) 3.41
Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. Bone Marrow Transplant (2001) 3.35
Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med (1994) 3.26
Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry (1996) 3.00
The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat Struct Biol (1996) 2.94
Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells. J Exp Med (1983) 2.93
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Biochemical and genetic evidence for a pseudoknot structure at the 3' terminus of the poliovirus RNA genome and its role in viral RNA amplification. J Virol (1993) 2.65
Functional analysis of CAR, the target sequence for the Rev protein of HIV-1. Science (1989) 2.62
Flexibility and function in HIV-1 protease. Nat Struct Biol (1995) 2.49
Analysis of the backbone dynamics of interleukin-1 beta using two-dimensional inverse detected heteronuclear 15N-1H NMR spectroscopy. Biochemistry (1990) 2.36
A theoretical model successfully identifies features of hepatitis B virus capsid assembly. Biochemistry (1999) 2.34
Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology (1990) 2.33
Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly. Biochemistry (1995) 2.26
Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Sci (1997) 2.09
Statistics of RNA secondary structures. Biopolymers (1993) 2.06
An expanded transcriptional map of T7 bacteriophage. Reading of minor T7 promoter sites in vitro by Escherichia coli RNA polymerase. J Mol Biol (1977) 2.03
Solution NMR of proteins within polyacrylamide gels: diffusional properties and residual alignment by mechanical stress or embedding of oriented purple membranes. J Biomol NMR (2000) 2.01
Kinetics of folding of the all-beta sheet protein interleukin-1 beta. Science (1993) 1.95
Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA. Proc Natl Acad Sci U S A (1997) 1.90
Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med (1999) 1.88
The crystal structure of the SIV gp41 ectodomain at 1.47 A resolution. J Struct Biol (1999) 1.76
Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J Exp Med (1983) 1.69
In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection. J Infect Dis (2008) 1.67
N-terminal methionine-specific peptidase in Salmonella typhimurium. Proc Natl Acad Sci U S A (1987) 1.66
Assignment of the side-chain 1H and 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy. Biochemistry (1990) 1.65
Nucleotide sequence of the cloned gene for bacteriophage T7 RNA polymerase. J Mol Biol (1981) 1.62
Hexon-only binding of VP26 reflects differences between the hexon and penton conformations of VP5, the major capsid protein of herpes simplex virus. J Virol (1997) 1.57
Binding of Escherichia coli RNA polymerase to T7 DNA. Displacement of holoenzyme from promoter complexes by heparin. J Biol Chem (1977) 1.57
A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia. Proc Natl Acad Sci U S A (1984) 1.55
Molecular architecture of bacteriophage T4 capsid: vertex structure and bimodal binding of the stabilizing accessory protein, Soc. Virology (2000) 1.53
Extracellular slime associated with Proteus mirabilis during swarming. J Bacteriol (1983) 1.53
Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens. J Mol Biol (1998) 1.44
Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein. J Virol (1992) 1.43
Bone marrow transplantation for Fanconi anemia. Blood (1995) 1.42
Complete resonance assignment for the polypeptide backbone of interleukin 1 beta using three-dimensional heteronuclear NMR spectroscopy. Biochemistry (1990) 1.40
HIV-1 Rev expressed in recombinant Escherichia coli: purification, polymerization, and conformational properties. Biochemistry (1991) 1.38
Filamentous hemagglutinin of Bordetella pertussis. A bacterial adhesin formed as a 50-nm monomeric rigid rod based on a 19-residue repeat motif rich in beta strands and turns. J Mol Biol (1994) 1.38
Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol (1992) 1.38
Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol (2001) 1.34
Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism. J Biol Chem (1999) 1.33
Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272. Biochemistry (1996) 1.32
Diversity of core antigen epitopes of hepatitis B virus. Proc Natl Acad Sci U S A (2003) 1.30
Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding. J Virol (2003) 1.29
Tetrairidium, a four-atom cluster, is readily visible as a density label in three-dimensional cryo-EM maps of proteins at 10-25 A resolution. J Struct Biol (1999) 1.29
The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization. Protein Sci (1997) 1.29
High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy. Biochemistry (1991) 1.28
Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant (1998) 1.25
Multiple coding and the evolutionary properties of RNA secondary structure. J Theor Biol (1993) 1.24
Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am J Respir Cell Mol Biol (2001) 1.21
Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha-helix in the thumb subdomain. J Biol Chem (1994) 1.20
Identification of a potential HIV-induced source of bystander-mediated apoptosis in T cells: upregulation of trail in primary human macrophages by HIV-1 tat. J Biomed Sci (2001) 1.20
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Regulation of HIV-1 protease activity through cysteine modification. Biochemistry (1996) 1.18
Measurement of 3hJNC' connectivities across hydrogen bonds in a 30 kDa protein. J Biomol NMR (1999) 1.17
Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy. Protein Sci (1996) 1.16
Nucleolar protein B23 stimulates nuclear import of the HIV-1 Rev protein and NLS-conjugated albumin. Biochemistry (1997) 1.16
Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Bone Marrow Transplant (2001) 1.16
Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker. J Immunol (1987) 1.15
A powerful method of sequential proton resonance assignment in proteins using relayed 15N-1H multiple quantum coherence spectroscopy. FEBS Lett (1989) 1.15
Transcription of T7 DNA containing modified nucleotides by bacteriophage T7 specific RNA polymerase. J Biol Chem (1978) 1.15
Phage display of intact domains at high copy number: a system based on SOC, the small outer capsid protein of bacteriophage T4. Protein Sci (1996) 1.14
A specific replication origin in the chromosomal rDNA of Lytechinus variegatus. Nature (1982) 1.12
Comparison of nucleotide and deduced amino acid sequence of the 5' non-coding region and structural protein genes of the wild-type Japanese encephalitis virus strain SA14 and its attenuated vaccine derivatives. J Gen Virol (1994) 1.11
Correlation between differentiation, expression of monocyte-specific antigens, and cytotoxic functions in human promyelocytic cell lines treated with leukocyte-conditioned medium. J Immunol (1983) 1.10
Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. J Biol Chem (2001) 1.10
Avian retrovirus U3 and U5 DNA inverted repeats. Role Of nonsymmetrical nucleotides in promoting full-site integration by purified virion and bacterial recombinant integrases. J Biol Chem (1997) 1.10
Identification and localization of bound internal water in the solution structure of interleukin 1 beta by heteronuclear three-dimensional 1H rotating-frame Overhauser 15N-1H multiple quantum coherence NMR spectroscopy. Biochemistry (1990) 1.09
Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling. J Biol Chem (1997) 1.09